Conundrum Industrial Limited specializes in designing and developing artificial intelligence-based enterprise software tailored for various manufacturing sectors. The company's primary offering, Conundrum AIaaS, provides a platform for users to remotely monitor and control factory operations. This technology addresses critical issues such as predictive maintenance, optimization, and quality control across multiple industries, including chemical production, pulp and paper, oil and gas, steel and mining, and equipment manufacturing. Founded in 2018, Conundrum is headquartered in the United Kingdom, where it focuses on delivering innovative AI solutions to enhance operational efficiency in industrial settings.
Ellipsis Health, Inc. is a technology company based in San Francisco, California, that specializes in developing tools to enhance behavioral health through innovative analytics solutions. Founded in 2013, the company utilizes artificial intelligence to analyze patient speech and clinical data, creating a real-time, behavioral health vital sign for individuals. This platform provides a clinical-grade assessment of anxiety and depression severity, as well as sub-clinical evaluations of stress. By enabling healthcare systems to continuously screen for mental health conditions, Ellipsis Health aims to support patients in receiving timely and appropriate care, focusing primarily on depression and anxiety.
Treos Bio is a clinical-stage biotechnology company focused on developing precision cancer immunotherapies tailored to the genetic profiles of patients. Founded in 2013 and based in San Francisco, the company utilizes proprietary technology to predict individual responses to cancer immunotherapies. Treos Bio offers several products, including PEPI, a test that analyzes genetic data from blood or saliva samples to forecast an individual's immune response to specific antigens. The company also develops PolyPEPI immunotherapy vaccines targeting various cancers such as melanoma, lung cancer, and breast cancer, alongside the PolyPEPI CDx companion diagnostic test, which assesses the effectiveness of treatments for individual patients. Additionally, Treos Bio provides a melanoma screening test to identify individuals at high risk of developing the disease based on genetic information. Through the integration of computational data science and proprietary biomarkers, Treos Bio aims to personalize cancer treatment with targeted vaccines and diagnostic tools.
LGN Innovations, Inc. specializes in developing artificial intelligence-based perception systems aimed at achieving human-level perception for autonomous systems. Founded in 2018 and headquartered in San Francisco, California, with additional offices in London and Zagreb, the company offers products such as LGN Auto-Calibrate, which integrates AI with sensor arrays, and LGN Intelligent Select, designed to efficiently filter and compress data. LGN's technology enhances the resolution and imaging capabilities of electronic devices, making it applicable across various sectors, including automotive, retail, and satellite industries. By optimizing data capture and processing, LGN's solutions reduce costs and power consumption while enabling high-level autonomy even with lower-cost sensors.
Cytoseek Limited, founded in 2017 and based in Bristol, United Kingdom, specializes in developing innovative cell therapies aimed at treating cancer, heart disease, osteoarthritis, and diabetic wound healing. As a spinout from the University of Bristol, the company utilizes a unique cell membrane augmentation technology that enhances cell therapies by adding new functionalities, such as tissue-specific targeting and improved cell survivability. Currently, Cytoseek is conducting proof of principle studies to validate the effectiveness of its therapies and is actively seeking partnerships with other cell therapy companies to advance these treatments into clinical settings, ultimately aiming to improve human health.
Magdrive Limited develops a next generation of spacecraft propulsion for small satellites. The company offers technology of new plasma thruster that combines both high thrust of chemical rockets and the high efficiency of other electric thrusters. The company was incorporated in 2019 and is based in Didcot, United Kingdom.
Biomage focuses on single-cell analysis to advance life sciences by providing innovative computational methods to derive insights from biological data. The company has developed the Biomage Single Cell Platform, which allows researchers to efficiently analyze single-cell RNA sequencing data. This platform transforms complex datasets into actionable biological insights, facilitating research in both academia and industry. By streamlining the data analysis process, Biomage empowers scientists to enhance drug target discovery while making the application of advanced sequencing technologies more accessible and cost-effective.
Kernal Biologics, Inc. specializes in the design and development of mRNA immunotherapies aimed at treating diseases such as COVID-19 and various cancers. Founded in 2016 and headquartered in Cambridge, Massachusetts, the company utilizes its mRNA platform to assist researchers and organizations in creating vaccines and therapeutics. Kernal's innovative therapies instruct specific cells to produce their own therapeutic agents, thereby enhancing treatment efficacy. The company has garnered recognition for its work, receiving multiple awards from notable institutions, including Amgen and NASA. With a foundation rooted in research from MIT and Harvard, the team at Kernal Biologics possesses extensive expertise in the mRNA field, building on their prior successes in the biotechnology sector.
Phenomic AI is a developer of a drug discovery platform designed to discovery and optimize therapeutics directly against phenotypic assays.The company's platform uses artificial intelligence to analyze phenotypes in complex disease models including high-content co-culture and 3D assays, enabling pharmaceutical companies to discover drugs in an easier way.
Climax Foods Inc. is a company focused on producing plant-based food products that replicate the taste and texture of animal-based foods by leveraging artificial intelligence and data science. Founded in 2019 and based in Berkeley, California, the company employs advanced machine learning and predictive modeling frameworks to enhance food innovation processes. Its team of experts in data and food science utilizes the diverse plant kingdom to develop a new generation of plant-based foods, aiming to create superior flavor, texture, and nutrition at competitive prices. By prioritizing experimentation and optimization, Climax Foods seeks to revolutionize the food production system and provide alternatives that can outperform traditional animal-based products.
Universal Quantum Ltd is a company based in England, United Kingdom, established in 2018, focused on developing qubit quantum computers. The company's goal is to create advanced quantum computing solutions capable of addressing complex, real-world problems that would require billions of years for the fastest traditional supercomputers to resolve. By harnessing the principles of quantum mechanics, Universal Quantum aims to revolutionize computing and provide innovative solutions across various industries.
Temporall is a developer of a workplace intelligence platform that leverages artificial intelligence and analytics to enhance organizational effectiveness. The platform integrates and analyzes fragmented data from various sources within a company, providing leadership teams with critical performance insights. By employing machine learning techniques, Temporall enables organizations to receive expert recommendations and detailed reporting, ultimately guiding clients in optimizing their performance. The company's focus is on merging advanced technology with human expertise to address the strategic needs of its clients.
Oxford VR Limited, founded in 2016 and based in Oxford, United Kingdom, specializes in developing automated cognitive treatments for various clinical conditions, including fear of heights, psychosis, and social anxiety. Originating from research at Oxford University by Professor Daniel Freeman, the company harnesses immersive virtual reality technology to deliver therapy through a virtual coach. This innovative approach aims to significantly increase access to mental health treatments, making them faster, more effective, and lower in cost compared to traditional methods. Oxford VR focuses on creating clinically validated and user-centered therapies that not only benefit patients but also positively impact the healthcare system and the broader economy.
Mahana Therapeutics, Inc. develops an application for treating patients suffering from gastrointestinal (GI) diseases and conditions. The company offers Parallel, a clinically-validated and minimal-contact digital program for people with irritable bowel syndrome (IBS). Mahana Therapeutics, Inc. was formerly known as Mahana Health, Inc. and changed its name to Mahana Therapeutics, Inc. in July 2019. The company was incorporated in 2018 and is based in San Francisco, California. It has an additional location in London, United Kingdom.
LGN Innovations, Inc. specializes in developing artificial intelligence-based perception systems aimed at achieving human-level perception for autonomous systems. Founded in 2018 and headquartered in San Francisco, California, with additional offices in London and Zagreb, the company offers products such as LGN Auto-Calibrate, which integrates AI with sensor arrays, and LGN Intelligent Select, designed to efficiently filter and compress data. LGN's technology enhances the resolution and imaging capabilities of electronic devices, making it applicable across various sectors, including automotive, retail, and satellite industries. By optimizing data capture and processing, LGN's solutions reduce costs and power consumption while enabling high-level autonomy even with lower-cost sensors.
Ellipsis Health, Inc. is a technology company based in San Francisco, California, that specializes in developing tools to enhance behavioral health through innovative analytics solutions. Founded in 2013, the company utilizes artificial intelligence to analyze patient speech and clinical data, creating a real-time, behavioral health vital sign for individuals. This platform provides a clinical-grade assessment of anxiety and depression severity, as well as sub-clinical evaluations of stress. By enabling healthcare systems to continuously screen for mental health conditions, Ellipsis Health aims to support patients in receiving timely and appropriate care, focusing primarily on depression and anxiety.
Optellum Ltd is a company based in Oxford, United Kingdom, specializing in the development of AI-driven clinical decision support software for lung cancer diagnosis and treatment. Founded in 2015, Optellum aims to enhance cancer care by providing an end-to-end IT platform that facilitates personalized early diagnosis and therapeutic strategies for patients at high risk of developing lung cancer, which is the most common and deadliest form of cancer. The company's innovative software identifies at-risk individuals and streamlines optimal treatment options, leveraging machine learning to analyze vast datasets from numerous healthcare professionals. Optellum's team consists of experts in medical imaging, artificial intelligence, and clinical practice, many of whom have a history of successful innovations in the medical technology sector. They are supported by an advisory board of leading clinicians and deep learning specialists, and are actively expanding their product development team to further their mission in the fight against cancer.
Astroscreen protects brands and defends democracy from harmful social media manipulation campaigns also known as astroturfing.
Hadean Supercomputing Ltd., founded in 2015 and based in London, is a deep tech company focused on advancing cloud computing through its unique distributed platform. The platform allows developers to write and run code at any scale using their existing tools, eliminating the need for complex operations or tuning. At the core of Hadean's offerings is HadeanOS, a cloud-native operating system optimized for performance across massively distributed infrastructures. This system addresses the real-time demands of modern applications while simplifying operational complexities. Additionally, Hadean has developed the Aether Engine, a spatial simulation solution that empowers game developers to overcome traditional technical limitations, enabling them to achieve unprecedented scale and performance without excessive costs. By facilitating the development of applications for the cloud, Hadean allows users to enjoy seamless experiences across various devices and mediums, enhancing the potential for engagement and monetization in the evolving digital landscape.
Vital Biosciences Inc, founded in 2016 and based in Kitchener, Canada, develops innovative tools designed to monitor health and manage diseases. The company operates as a business-to-business (B2B) vertical portal specifically tailored for the life sciences industry. By focusing on the needs of this sector, Vital Biosciences aims to enhance health monitoring and disease management solutions.
Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.
BioBeats Group Ltd designs and develops an online platform BioBeats, that is a machine learning platform that measures biometrics and manages stress and wellness of individuals, employees, and patients in real-time, and helps them action that insight through engaging media. Its application is available for download on Android and iOS devices. The company was incorporated in 2011 and is based in London, United Kingdom.
FaceSoft is developing machine learning models and databases that improve 3D facial recognition and computer-generated facial reconstruction technologies. The spinout's reconstruction algorithm has been trained on a database of 2.5 million high-resolution 3D facial scans. The company was founded in 2017 and based in London, England.
Beyond Limited operates a platform that enables users to compare funeral director prices, services, and reviews in the United Kingdom. Founded in 2015 and based in London, the company provides various solutions related to end-of-life planning, including arrangements for direct cremation, funeral financing, will writing, and estate settlement. Formerly known as Funeralbooker Ltd, Beyond aims to assist customers in making informed decisions during a difficult time.
Active Global Specialised Caregivers Pte Ltd is a Singapore-based company that specializes in providing home personal care, live-in caregiver, and respite care services. Established in 2012, the company offers tailored caregiver support for individuals dealing with various health conditions, including cancer, dementia, diabetes, stroke, heart disease, Parkinson’s disease, and visual or hearing impairments. Additionally, it addresses nutrition and elimination issues, schizophrenia, stoma and wound care, as well as allergies. Active Global Specialised Caregivers aims to enhance the quality of life for patients by delivering compassionate and professional care in the comfort of their own homes.
Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.
Sparrho is a London-based company that operates a discovery platform for scientific information, designed to make research more accessible. Founded in 2013 by two Oxbridge scientists, the platform combines artificial intelligence with insights from PhD experts to aggregate, distill, and recommend relevant scientific content from a variety of sources, including journals, patents, and conferences. It provides users with customized and filtered recommendations, allowing them to save, share, and disseminate discoveries. Sparrho aims to enhance trust in scientific information and caters to a diverse clientele, including Fortune 500 companies, by delivering real-time, curated updates on the latest research developments.
Hadean Supercomputing Ltd., founded in 2015 and based in London, is a deep tech company focused on advancing cloud computing through its unique distributed platform. The platform allows developers to write and run code at any scale using their existing tools, eliminating the need for complex operations or tuning. At the core of Hadean's offerings is HadeanOS, a cloud-native operating system optimized for performance across massively distributed infrastructures. This system addresses the real-time demands of modern applications while simplifying operational complexities. Additionally, Hadean has developed the Aether Engine, a spatial simulation solution that empowers game developers to overcome traditional technical limitations, enabling them to achieve unprecedented scale and performance without excessive costs. By facilitating the development of applications for the cloud, Hadean allows users to enjoy seamless experiences across various devices and mediums, enhancing the potential for engagement and monetization in the evolving digital landscape.
Beyond Limited operates a platform that enables users to compare funeral director prices, services, and reviews in the United Kingdom. Founded in 2015 and based in London, the company provides various solutions related to end-of-life planning, including arrangements for direct cremation, funeral financing, will writing, and estate settlement. Formerly known as Funeralbooker Ltd, Beyond aims to assist customers in making informed decisions during a difficult time.
BioBeats Group Ltd designs and develops an online platform BioBeats, that is a machine learning platform that measures biometrics and manages stress and wellness of individuals, employees, and patients in real-time, and helps them action that insight through engaging media. Its application is available for download on Android and iOS devices. The company was incorporated in 2011 and is based in London, United Kingdom.